Prostaglandins enhanced the interferon response and therapeutic activity of interferon inducers in Friend leukemia virus-infected mice. A similar enhancement in interferon responsiveness but not antiviral activity was observed in mice infected with rapidly acute viruses.
Interferon has the potential of being an effective antiviral as well as antineoplastic agent (7, 10) . This prospect has encouraged exploration of methods of utilizing the interferon system. One approach has been identification and development of agents capable of stimulating the host's cells to produce their own interferon. There are several agents which are capable of inducing interferon production in a variety of animal species. For example, a synthetic double-stranded ribonucleic acid has been reported to be an effective interferon inducer in nonhuman primates and cancer patients (3) . These developments suggest that use of inducers might be a viable approach to the utilization of the interferon system. However, one problem confronting the use of these agents is that animals exposed to daily doses of an inducer or infected with viruses or carrying certain types of neoplasias develop a suppressed ability to produce interferon (9, 11 ). This hyporeactive state may limit the therapeutic efficacy of interferon inducers. Recently this laboratory reported that certain prostaglandins, when administered with interferon inducers, could restore the interferon responsiveness ofvirus-infected animals (8) . These results suggested that prostaglandins, when administered with interferon inducers, might significantly enhance the therapeutic efficacy of such agents.
The studies described in this report were initiated to determine whether prostaglandins could enhance the antiviral efficacy of interferon inducers. (8) . An internal laboratory reference murine interferon standard was included with each interferon assay, and the sensitivity of each assay was compared with the international murine standard (G 002-904-511) obtained from the National Institutes of Health. In our system the international standard had a mean titer of 5,800 U/ml compared with the accepted titer of 6,500 U/ml.
MATERIALS AND METHODS

Mice
Prostaglandins. Prostaglandins were furnished by F. H. Lincoln (Upjohn) and were stored as 5-mg/ml solutions in 95% ethanol at -20°C. They were diluted in PBS just before use. Prostaglandins were greater than 97% pure.
RESULTS
Since certain prostaglandins can restore the ability of virus-infected mice to respond to interferon induction, initial studies were designed to determine whether they could also increase therapeutic efficacy. Table 2 and Fig. 1 to 3 represent the mean of three separate studies.
The serum interferon response of FLV-infected mice is presented in Table 2 . As the infection progressed, the ability of animals to respond to poly(rI:rC), ABMP, or tilorone hy- c Significantly higher interferon titer than inducer administered with PBS at that period in FLV-infected mice, using a chi-square analysis (P < 0.05).
drochloride progressively decreased. By 3 weeks after infection, mice had a suppressed response to each of the inducers. In each case, however, prostaglandin El and Fl, enhanced the ability of hyporeactive virus-infected animals to respond to interferon induction.
In Fig. 1 the effect of poly(rI:rC) on spleen weights of FLV-infected mice is illustrated. Both prostaglandin El and Fi,. enhanced the therapeutic efficacy of poly(rI:rC). In both cases spleen weights were consistently lower than in animals that received poly(rI:rC) with PBS.
When ABMP was used as the inducer (Fig. 2 Tilorone was the most effective of the inducers evaluated (Fig. 3) . Again, prostaglandin El and F1. enhanced the effect of the inducer. As the infection progressed, tilorone with PBS became less effective, but when administered with prostaglandins it maintained antiviral effect.
Inducers or prostaglandins or both did not significantly affect spleen weights in infected or uninfected control mice. regard to spleen weights and interferon responses were very similar to the previous study where animals developed hyporeactivity about week 3 of infection and prostaglandins restored the response of impaired mice. A concomitant decrease in spleen weights was again observed lasting through the 10 weeks of therapy. Continuation of therapy for a 10-week period further increased the life span and percent survival (Table 3) Some degree of caution needs to be inserted here, since host defense mechanisms other than or in conjunction with interferon are also important to resistance to and recovery from infection or neoplasia. For example, interferon can specifically activate macrophages to attack and destroy tumor cells (6) . Likewise, prostaglandins have been implicated in a decreased ability of macrophages to mediate cellular cytotoxicity (5) . Prostaglandins can also suppress lymphocyte mytogenesis (2, 4, 13) . These results suggest that certain prostaglandins may suppress certain components of the host immune system. However, these reports also need to be interpreted with caution in light of the results presented in this report which suggest that prostaglandins may have value in the treatment of specific disease states and careful consideration should be given to their possible-use.
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